Poseida Therapeutics
PSTX
$2.13
Share price
3.90%
Change (1 day)
-13.06%
Change (1 year)
Poseida Therapeutics (PSTX) - Cash on Hand
Cash on Hand as of December 2023 : $0.21 B
According to Poseida Therapeutics's latest financial reports the company has $0.21 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Poseida Therapeutics - Cash on Hand chart (from 2019 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.21 B | -24.88% |
| 2022-12-31 | $0.28 B | 36.92% |
| 2021-12-31 | $0.20 B | -33.26% |
| 2020-12-31 | $0.30 B | 146.69% |
| 2019-12-31 | $0.12 B | 312.3% |
| 2018-12-31 | $30.39 M | 94.53% |
| 2017-12-31 | $15.62 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | -1.89% | 🇺🇸 USA |